Cargando…
Can COVID‐19 accelerate neurodegeneration?
COVID‐19 may accelerate neurodegeneration in patients with neurodegenerative disease.
Autores principales: | Salari, Mehri, Etemadifar, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271265/ https://www.ncbi.nlm.nih.gov/pubmed/34267913 http://dx.doi.org/10.1002/ccr3.4433 |
Ejemplares similares
-
Autoimmune meningoencephalitis associated with anti‐glutamic acid decarboxylase antibody following COVID‐19 infection: A case report
por: Salari, Mehri, et al.
Publicado: (2022) -
Atypical parkinsonism can be a presenting feature of late‐onset Huntington's disease
por: Salari, Mehri, et al.
Publicado: (2022) -
Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse
por: Etemadifar, Masoud, et al.
Publicado: (2022) -
Atypical parkinsonism and self‐mutilation: A new lens on the old concept
por: Salari, Mehri, et al.
Publicado: (2021) -
Atypical parkinsonism and self‐mutilation: A new lens on the old concept
por: Salari, Mehri, et al.
Publicado: (2021)